Acute kidney injury induced by COVID-19: a literature review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/39997 |
Resumo: | Introduction: The COVID-19 infection has presented significant complications to individuals affected by the disease, among them, acute kidney injury has been showing an increasing incidence. Objective: to know the prevalence of kidney injuries associated with COVID-19, as well as its main clinical and laboratory manifestations. Method: A narrative literature review was performed using the Scientific Electronic Library Online (SciELO) and PubMed databases. For the search, the descriptors were used: “Sars-CoV-2”, “COVID-19” and “Acute Kidney Injury”. Complete articles were selected, published in the languages: English, Spanish and Portuguese, during the year 2020 to 2023. 482 scientific productions were pre-selected, of which 59 corresponded to the inclusion criteria: complete articles; in English, Portuguese and Spanish and related to the objective used in this study. Results and Discussion: Reports of previous outbreaks of severe acute respiratory syndrome described the prevalence of acute kidney injury, ranging from 5% to 15% of all cases, requiring the use of renal replacement therapy for 5% to 58% of critically ill patients. The impact of acute kidney injury on the outcomes of patients with SARS (SARS)-CoV-2 remains unclear but is of particular interest for introducing early therapy in acute patients as well as contributing to a better definition of prognosis. The extent (?) to which the development of acute kidney injury is associated with severe COVID-19 is unclear, given its association with relative immune dysregulation and exaggerated inflammatory responses. However, it is concluded that patients with the development of acute kidney injury have a worse prognosis and a higher mortality rate. |
id |
UNIFEI_e20fe6775ff094487bfd2c77e0af7343 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/39997 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Acute kidney injury induced by COVID-19: a literature review Daño renal agudo inducido por COVID-19: una revisión de la literatura Lesão renal aguda induzida por COVID-19: uma revisão de literaturaCOVID-19Lesión renal agudaSARS-CoV-2.COVID-19Injúria Renal AgudaSARS-CoV-2.COVID-19Acute kidney injurySARS-CoV-2.Introduction: The COVID-19 infection has presented significant complications to individuals affected by the disease, among them, acute kidney injury has been showing an increasing incidence. Objective: to know the prevalence of kidney injuries associated with COVID-19, as well as its main clinical and laboratory manifestations. Method: A narrative literature review was performed using the Scientific Electronic Library Online (SciELO) and PubMed databases. For the search, the descriptors were used: “Sars-CoV-2”, “COVID-19” and “Acute Kidney Injury”. Complete articles were selected, published in the languages: English, Spanish and Portuguese, during the year 2020 to 2023. 482 scientific productions were pre-selected, of which 59 corresponded to the inclusion criteria: complete articles; in English, Portuguese and Spanish and related to the objective used in this study. Results and Discussion: Reports of previous outbreaks of severe acute respiratory syndrome described the prevalence of acute kidney injury, ranging from 5% to 15% of all cases, requiring the use of renal replacement therapy for 5% to 58% of critically ill patients. The impact of acute kidney injury on the outcomes of patients with SARS (SARS)-CoV-2 remains unclear but is of particular interest for introducing early therapy in acute patients as well as contributing to a better definition of prognosis. The extent (?) to which the development of acute kidney injury is associated with severe COVID-19 is unclear, given its association with relative immune dysregulation and exaggerated inflammatory responses. However, it is concluded that patients with the development of acute kidney injury have a worse prognosis and a higher mortality rate.Introducción: La infección por COVID-19 ha presentado importantes complicaciones a los afectados por la enfermedad, entre ellas, la insuficiencia renal aguda ha venido mostrando una incidencia creciente. Objetivo: conocer la prevalencia de las lesiones renales asociadas a la COVID-19, así como sus principales manifestaciones clínicas y de laboratorio. Método: Se realizó una revisión narrativa de la literatura utilizando las bases de datos Scientific Electronic Library Online (SciELO) y PubMed. Para la búsqueda se utilizaron los descriptores: “Sars-CoV-2”, “COVID-19” y “Acute Kidney Injury”. Se seleccionaron artículos completos, publicados en los idiomas: inglés, español y portugués, durante el año 2020 a 2023. Se preseleccionaron 482 producciones científicas, de las cuales 59 correspondieron a los criterios de inclusión: artículos completos; en inglés, portugués y español y relacionado con el objetivo utilizado en este estudio. Resultados y Discusión: Reportes de brotes previos de síndrome respiratorio agudo severo describieron la prevalencia de daño renal agudo, variando del 5% al 15% de todos los casos, requiriendo el uso de terapia de reemplazo renal para el 5% al 58% de pacientes críticamente enfermos. El impacto de la lesión renal aguda en los resultados de los pacientes con SARS (SARS)-CoV-2 aún no está claro, pero es de particular interés para introducir una terapia temprana en pacientes agudos y contribuir a una mejor definición del pronóstico. La medida (?) en la que el desarrollo de lesión renal aguda se asocia con COVID-19 grave no está clara, dada su asociación con una desregulación inmunitaria relativa y respuestas inflamatorias exageradas. Sin embargo, se concluye que los pacientes con desarrollo de insuficiencia renal aguda tienen un peor pronóstico y una mayor tasa de mortalidad.Introdução: A infecção por COVID-19 tem apresentado complicações significativas aos indivíduos acometidos pela doença, dentre elas, a lesão renal aguda vem apresentando uma incidência cada vez maior. Objetivo: conhecer a prevalência das lesões renais associadas a COVID-19, bem como, suas principais manifestações clínicas e laboratoriais. Método: Foi realizada uma revisão narrativa de literatura, utilizando as bases de dados Scientific Eletronic Library Online (SciELO) e PubMed. Para a busca, foram utilizados os descritores: “Sars-CoV-2”, “COVID-19” e “Injúria Renal Aguda”. Foram selecionados artigos completos, publicados nas línguas: inglês, espanhol e português, durante o ano de 2020 a 2023. Foram pré-selecionadas 482 produções cientificas, das quais 59 correspondiam aos critérios de inclusão: artigos completos; nos idiomas inglês, português e espanhol e relacionados ao objetivo utilizado neste estudo. Resultados e Discussão: Relatórios de surtos anteriores de síndrome respiratória aguda grave descreveram prevalência de lesão renal aguda, variando de 5% a 15% do total de casos, com necessidade de utilização de terapia renal substitutiva para 5% a 58% dos pacientes críticos. O impacto da lesão renal aguda nos resultados dos pacientes com Sars (SARS) -CoV-2 permanecem pouco claros, mas são de particular interesse, para introdução de terapêutica precoce nos pacientes agudos bem como contribuição para uma melhor definição de prognóstico. A medida (?) em que o desenvolvimento de lesão renal aguda está associada à COVID-19 grave, não é clara, dada a sua associação com a desregulação imune relativa e respostas inflamatórias exageradas. No entanto, conclui-se que pacientes com desenvolvimento de lesão renal aguda apresentam pior prognóstico e maior taxa de mortalidade.Research, Society and Development2023-02-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3999710.33448/rsd-v12i2.39997Research, Society and Development; Vol. 12 No. 2; e7012239997Research, Society and Development; Vol. 12 Núm. 2; e7012239997Research, Society and Development; v. 12 n. 2; e70122399972525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/39997/32902Copyright (c) 2023 Lillian Batista Terceros; Marta Driemeierhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessTerceros, Lillian Batista Driemeier, Marta2023-02-14T20:07:52Zoai:ojs.pkp.sfu.ca:article/39997Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-02-14T20:07:52Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Acute kidney injury induced by COVID-19: a literature review Daño renal agudo inducido por COVID-19: una revisión de la literatura Lesão renal aguda induzida por COVID-19: uma revisão de literatura |
title |
Acute kidney injury induced by COVID-19: a literature review |
spellingShingle |
Acute kidney injury induced by COVID-19: a literature review Terceros, Lillian Batista COVID-19 Lesión renal aguda SARS-CoV-2. COVID-19 Injúria Renal Aguda SARS-CoV-2. COVID-19 Acute kidney injury SARS-CoV-2. |
title_short |
Acute kidney injury induced by COVID-19: a literature review |
title_full |
Acute kidney injury induced by COVID-19: a literature review |
title_fullStr |
Acute kidney injury induced by COVID-19: a literature review |
title_full_unstemmed |
Acute kidney injury induced by COVID-19: a literature review |
title_sort |
Acute kidney injury induced by COVID-19: a literature review |
author |
Terceros, Lillian Batista |
author_facet |
Terceros, Lillian Batista Driemeier, Marta |
author_role |
author |
author2 |
Driemeier, Marta |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Terceros, Lillian Batista Driemeier, Marta |
dc.subject.por.fl_str_mv |
COVID-19 Lesión renal aguda SARS-CoV-2. COVID-19 Injúria Renal Aguda SARS-CoV-2. COVID-19 Acute kidney injury SARS-CoV-2. |
topic |
COVID-19 Lesión renal aguda SARS-CoV-2. COVID-19 Injúria Renal Aguda SARS-CoV-2. COVID-19 Acute kidney injury SARS-CoV-2. |
description |
Introduction: The COVID-19 infection has presented significant complications to individuals affected by the disease, among them, acute kidney injury has been showing an increasing incidence. Objective: to know the prevalence of kidney injuries associated with COVID-19, as well as its main clinical and laboratory manifestations. Method: A narrative literature review was performed using the Scientific Electronic Library Online (SciELO) and PubMed databases. For the search, the descriptors were used: “Sars-CoV-2”, “COVID-19” and “Acute Kidney Injury”. Complete articles were selected, published in the languages: English, Spanish and Portuguese, during the year 2020 to 2023. 482 scientific productions were pre-selected, of which 59 corresponded to the inclusion criteria: complete articles; in English, Portuguese and Spanish and related to the objective used in this study. Results and Discussion: Reports of previous outbreaks of severe acute respiratory syndrome described the prevalence of acute kidney injury, ranging from 5% to 15% of all cases, requiring the use of renal replacement therapy for 5% to 58% of critically ill patients. The impact of acute kidney injury on the outcomes of patients with SARS (SARS)-CoV-2 remains unclear but is of particular interest for introducing early therapy in acute patients as well as contributing to a better definition of prognosis. The extent (?) to which the development of acute kidney injury is associated with severe COVID-19 is unclear, given its association with relative immune dysregulation and exaggerated inflammatory responses. However, it is concluded that patients with the development of acute kidney injury have a worse prognosis and a higher mortality rate. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-02-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/39997 10.33448/rsd-v12i2.39997 |
url |
https://rsdjournal.org/index.php/rsd/article/view/39997 |
identifier_str_mv |
10.33448/rsd-v12i2.39997 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/39997/32902 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Lillian Batista Terceros; Marta Driemeier https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Lillian Batista Terceros; Marta Driemeier https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 12 No. 2; e7012239997 Research, Society and Development; Vol. 12 Núm. 2; e7012239997 Research, Society and Development; v. 12 n. 2; e7012239997 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052617453469696 |